Skip to main content
. 2011 Dec 26;11:142. doi: 10.1186/1471-230X-11-142

Table 1.

Clinical features of patients of hepatic angiomyosarcoma

Case Sex Age (year) Chief Complaint Comobidity Alcohol Drinking Hepatitis Treatment Metastasis Follow-up Immunostaining
1 M 65 liver tumor DM yes none C none 3 M CD31, Factor VIII
2 M 62 abdominal pain HTN, gout No none C none 1 W CD31, vimentin
3 M 67 right subcostal pain DM, HTN No none OP+C/T lung, subphrenic, peritoneum 44 M CD31, CD34, Factor VIII, FLI-1, vimentin,
4 F 69 general weakness DM, HTN, gastric GIST No none OP+C/T+R/T brain, spine 37 M CD31
5 M 83 general edema HTN, CAD, COPD No none C none 8 M CD31
6 M 56 epigastric mass DM, HTN, liver rupture No none TAE+OP none 4 M CD31
7 F 60 liver tumor hypothyroidism, uremia No HCV C none 2 M CD34
8 F 63 right abdominal pain liver rupture No none OP+C/T peritoneum, duodeum, colon 3 M CD31
9 M 56 liver tumor L/C, EV, left hip AVN yes HCV TAE+HAIC none 24 M CD31, CD34, D2-40, c-kit, Factor VIII

DM = diabetes mellitus; HTN = hypertension; GIST = gastrointestinal stromal tumor; CAD = coronary arterial disease; COPD = chronic obstructive pulmonary disease; L/C = liver cirrhosis; EV = esophageal varies; AVN = avscular necrosis; OP = operation; TAE = transarterial embolization; C/T = chemotherapy; C = conservative treatment; HAIC = hepatic arterial infusion chemotherapy; M = month; W = week.